SEQUANA MEDICAL ANNOUNCES DECISION OF MAJOR SHAREHOLDERS TO INVEST IN SECOND TRANCHE OF CONVERTIBLE BRIDGE LOAN Ghent, Belgium, 6 December 2024 – (Euronext Brussels: SEQUA) (the "Company" or "Sequana ...
There's new hope for people battling advanced bladder cancer who do not respond to first-line therapy, researchers report.
The development of an effective vaccine against the hepatitis C virus (HCV) has posed a significant challenge for decades due ...
Globally, approximately 58 million people are chronically infected with HCV, resulting in 290,000 annual deaths due to complications such as liver ...
Weight loss methods are changing at an unparalleled rate. What was previously restricted to conventional diets and strenuous ...
AstraZeneca's supplemental Biologics License Application (sBLA) for IMFINZI® (durvalumab) has been accepted and granted Priority Review in the US for the treatment of patients with muscle-invasive ...
Researchers develop and evaluate the accuracy, safety, and utility of large language model-generated emergency medicine ...